Pharma Pioneer

What Does Mometasone Topical Do?

11 May 2024
3 min read

Mometasone topical, commercially known as Elocon, is a potent corticosteroid medication developed by Novartis Pharmaceuticals Corporation. It targets the inflammation process by reducing the actions of chemicals in the body that cause inflammation. This medication is classified under the drug class of topical steroids and is primarily used to alleviate the symptoms of various skin conditions, including eczema, psoriasis, and rashes. It is not intended for ophthalmic or oral use and is not approved for use in children under 2 years of age.

Mechanism of Action of Mometasone Topical

Mometasone topical exerts its anti-inflammatory effects by binding to the glucocorticoid receptor in the cell cytoplasm of target cells. Once bound, the drug-receptor complex translocates to the cell nucleus, where it modulates the transcription of certain genes, leading to a decrease in the production of various inflammatory mediators. This results in reduced inflammation, itching, and swelling of the affected skin areas.

How to Use Mometasone Topical

Mometasone topical is applied directly to the skin from a tube and is available in various forms, including cream, lotion, and ointment, each with a concentration of 0.1%. The medication should be applied in a thin layer to the affected area once or twice daily, depending on the severity of the condition and the instructions provided by a healthcare professional. It is important to wash hands before and after application, unless the hands are the treatment area. The medication should not be applied to large areas of skin or covered with a bandage, as this can increase absorption and the risk of side effects.

Side Effects of Mometasone Topical

As with other topical steroids, mometasone topical can cause side effects, which may include red or pus-filled bumps, acne, mild itching, tingling, or burning. More serious side effects can occur, such as severe skin irritation, blurred vision, high blood sugar, and others. Long-term use can lead to thinning of the skin, easy bruising, and systemic absorption of the medication, which may affect glucose levels. Children are at a higher risk of systemic absorption and should not use the medication for longer than three weeks without medical supervision.

Contraindications and Precautions

Mometasone topical is contraindicated in individuals with a known allergy to mometasone or any of the product's components. It should not be used to treat diaper rash or on children under 2 years of age. People with diabetes should be cautious as the medication may affect blood sugar levels. The drug is also not recommended for use on the face, underarms, or groin area unless directed by a doctor due to the potential for increased systemic absorption in these areas.

Drug Interactions with Mometasone Topical

Mometasone topical can interact with other medications, particularly other steroidal products that are applied to the skin or taken orally. This can lead to increased side effects or reduced effectiveness of either drug. Patients should inform their healthcare provider of all medications they are currently using to avoid potential drug interactions.

In conclusion, mometasone topical is a potent treatment option for various skin conditions characterized by inflammation. While it can provide relief from symptoms like pain, redness, and itching, it should be used with caution and under the guidance of a healthcare professional to minimize the risk of side effects and ensure safe and effective treatment.

How to obtain the latest development progress of all drugs?

In the Synapse database, you can keep abreast of the latest research and development advances of all drugs anywhere and anytime, daily or weekly, through the "Set Alert" function. Click on the image below to embark on a brand new journey of drug discovery!

图形用户界面, 应用程序

描述已自动生成

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

图形用户界面, 应用程序

描述已自动生成

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Pharma Frontiers: Daily Digest of Global Pharmaceutical News - May 11
Pharma Frontiers
11 min read
Pharma Frontiers: Daily Digest of Global Pharmaceutical News - May 11
11 May 2024
May 11th latest updates in the global new drug development field, including progress in new drug research and development, transaction information, and partnership developments.
Read →
What are the characteristics of seamless Phase I/II clinical trials?
"What" Series
3 min read
What are the characteristics of seamless Phase I/II clinical trials?
11 May 2024
Seamless Phase I/II clinical trials are a type of clinical trial design that combines elements of both Phase I and Phase II trials into a single study.
Read →
FDA Approves Merus' Zeno for Expedited NRG1+ Lung and Pancreatic Cancer Treatment
Latest Hotspot
3 min read
FDA Approves Merus' Zeno for Expedited NRG1+ Lung and Pancreatic Cancer Treatment
11 May 2024
Merus Reveals FDA Approval and Expedited Assessment of BLA for Zeno to Manage NRG1+ Lung and Pancreatic Cancer.
Read →
What Does Canagliflozin Do?
Pharma Pioneer
4 min read
What Does Canagliflozin Do?
11 May 2024
Canagliflozin, marketed under the brand name Invokana, is a medication developed by Janssen Pharmaceuticals, a division of Johnson & Johnson, for the treatment of type 2 diabetes mellitus.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.